IS8373A - Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn - Google Patents

Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn

Info

Publication number
IS8373A
IS8373A IS8373A IS8373A IS8373A IS 8373 A IS8373 A IS 8373A IS 8373 A IS8373 A IS 8373A IS 8373 A IS8373 A IS 8373A IS 8373 A IS8373 A IS 8373A
Authority
IS
Iceland
Prior art keywords
oxcarbazepine
sleep
pain
improvement
treatment
Prior art date
Application number
IS8373A
Other languages
English (en)
Inventor
Manning Donald
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0320637A external-priority patent/GB0320637D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8373A publication Critical patent/IS8373A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS8373A 2003-09-03 2006-03-24 Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn IS8373A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0320637A GB0320637D0 (en) 2003-09-03 2003-09-03 Organic compounds
US53737804P 2004-01-16 2004-01-16
PCT/EP2004/009797 WO2005020968A2 (en) 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep

Publications (1)

Publication Number Publication Date
IS8373A true IS8373A (is) 2006-03-24

Family

ID=34276821

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8373A IS8373A (is) 2003-09-03 2006-03-24 Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn

Country Status (18)

Country Link
US (1) US20060270658A1 (is)
EP (1) EP1663247B1 (is)
JP (1) JP2007513056A (is)
KR (1) KR20060118426A (is)
AT (1) ATE446759T1 (is)
AU (1) AU2004268381B2 (is)
BR (1) BRPI0414112A (is)
CA (1) CA2537060A1 (is)
DE (1) DE602004023861D1 (is)
IL (1) IL173822A0 (is)
IS (1) IS8373A (is)
MA (1) MA28036A1 (is)
MX (1) MXPA06002392A (is)
NO (1) NO20061515L (is)
RU (1) RU2369393C2 (is)
SG (1) SG146631A1 (is)
TN (1) TNSN06072A1 (is)
WO (1) WO2005020968A2 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
EP2359830B1 (en) * 2006-04-26 2012-09-19 Supernus Pharmaceuticals, Inc. Controlled released preparations of oxcarbazepine having sigmoidal release profile
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
KR102486435B1 (ko) 2022-04-25 2023-01-10 주식회사 제이비플랜트 산업용 냉동기기의 친환경 패널의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
US4353887A (en) 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
CO4920215A1 (es) 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
JP2006509735A (ja) * 2002-10-17 2006-03-23 ノバルティス アクチエンゲゼルシャフト オクスカルバゼピンまたはその誘導体およびcox2インヒビターからなる疼痛処置用医薬組成物

Also Published As

Publication number Publication date
SG146631A1 (en) 2008-10-30
AU2004268381B2 (en) 2009-06-18
IL173822A0 (en) 2006-07-05
MXPA06002392A (es) 2006-06-20
US20060270658A1 (en) 2006-11-30
CA2537060A1 (en) 2005-03-10
RU2006110550A (ru) 2007-12-20
AU2004268381A1 (en) 2005-03-10
JP2007513056A (ja) 2007-05-24
WO2005020968A3 (en) 2005-05-19
BRPI0414112A (pt) 2006-10-31
EP1663247B1 (en) 2009-10-28
ATE446759T1 (de) 2009-11-15
NO20061515L (no) 2006-06-06
TNSN06072A1 (en) 2007-10-03
RU2369393C2 (ru) 2009-10-10
DE602004023861D1 (de) 2009-12-10
MA28036A1 (fr) 2006-07-03
KR20060118426A (ko) 2006-11-23
WO2005020968A2 (en) 2005-03-10
EP1663247A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
EA200800056A1 (ru) Каннабиноидный активный фармацевтический ингредиент для лекарственных форм
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
DOP2005000039A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
MX2009011900A (es) Curacion de herida diabetica.
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
NO20073774L (no) Terapeutiske forbindelser for intranasal administrering av ketorolac
WO2009142772A3 (en) Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
IS8373A (is) Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn
EA201100916A1 (ru) Комбинация инсулина с триазиновыми производными и их применение для лечения диабета
GB2446341A (en) Method and system for transdermal drug delivery
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
TW200626133A (en) Oral medication for twice-daily administration
WO2006124544A3 (en) Use of tyrosine kinase inhibitors in the treatment of metabolic disorders
TW200515912A (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
DK1265629T3 (da) Anvendelse af væksthormon i lav dosis
PT1817029E (pt) Derivado isoxazólico para o alívio de dores neuropáticas